Professional Documents
Culture Documents
DETERMINING BREAST
CANCER BIOMARKER
STATUS AND ASSOCIATED
MORPHOLOGICAL
FEATURES USING DEEP
LEARNING
Breast cancer diagnosis and characterization requires evaluation of biomarkers that
are within or on the surface of tumor cells.
These include estrogen receptor, progesterone receptor and human epidermal growth
factor receptor 2 or HER2.
The levels of these markers determine how the person with breast cancer is treated
in the clinical setting.
The study explores the ability of artificial intelligence to determine the status of these
markers in digitized images without the need for immunohistochemical staining.
The study demonstrates that artificial intelligence can predict the status of all 3
biomarkers in pathology images and additional testing identifies specific imaging
features that enable these predictions.
This type of study and approach can reduce costs and time needed to improve the
quality of biomarker detection.
METHODS
ROC curves were calculated for both patch and slide testing:
>135 million patches, 181 slides. 3274 slides, 1249 cases, 37
sites
RESULTS
The ROC curves for the patch level are: 0.9339 (65%
confidence interval 0.936 - 0.941), 0.938 (0.936-0.940) and
0.808 (0.802-0.813) for estrogen receptor, progesterone
receptor and HER2 respectively.
The ROC curves for slide level are: 0.86 (95% confidence
interval 0.84-0.87), 0.75 (0.73-0.77) and 0.6 (0.56-0.64) for
estrogen receptor, progesterone receptor and HER2
respectively.
CONCLUSIONS
REFERENCES
Gamble, P., Jaroensri, R., Wang, H., Tan, F., Moran, M., Brown,
T., Flament-auvigne, I., Rakha, E. A., Toss, M., Dabbs, D. J.,
Regitnig, P., Olson, N., Wren, J. H., Robinson, C., Corrado, G.
S., Peng, L. H., Liu, Y., Mermel, C. H., Steiner, D. F., & Chen, P.
C. (2021). learning. 1–12.